Clinical Trial Update: Leflunomide EfficAcy Response Related to Dosing Regimen in Early Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

A Phase 3 trial update evaluates the relationship between dosing regimens of leflunomide and treatment efficacy in early rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ARAVA (leflunomide)

Snippet

Sponsor: Sanofi | Conditions: Arthritis, Rheumatoid | Phase 3 | Status: COMPLETED